Ellevest Inc’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $740K | Sell |
1,405
-55
| -4% | -$30.8K | 0.09% | 168 |
|
|
2026
Q1 | $820K | Buy |
1,460
+147
| +11% | +$94.3K | 0.11% | 128 |
|
|
2025
Q4 | $888K | Sell |
1,313
-98
| -7% | -$66.7K | 0.12% | 119 |
|
|
2025
Q3 | $901K | Buy |
1,411
+268
| +23% | +$163K | 0.13% | 113 |
|
|
2025
Q2 | $613K | Buy |
1,143
+24
| +2% | +$11.5K | 0.1% | 157 |
|
|
2025
Q1 | $470K | Buy |
1,119
+119
| +12% | +$51.7K | 0.03% | 208 |
|
|
2024
Q4 | $413K | Sell |
1,000
-149
| -13% | -$65.4K | 0.02% | 238 |
|
|
2024
Q3 | $580K | Sell |
1,149
-28
| -2% | -$13.6K | 0.03% | 186 |
|
|
2024
Q2 | $573K | Buy |
1,177
+114
| +11% | +$57.2K | 0.03% | 179 |
|
|
2024
Q1 | $574K | Sell |
1,063
-26
| -2% | -$14.2K | 0.04% | 171 |
|
|
2023
Q4 | $604K | Buy |
1,089
+95
| +10% | +$44.6K | 0.04% | 151 |
|
|
2023
Q3 | $435K | Buy |
994
+93
| +10% | +$46.4K | 0.03% | 183 |
|
|
2023
Q2 | $453K | Buy |
901
+40
| +5% | +$19.2K | 0.03% | 173 |
|
|
2023
Q1 | $431K | Buy |
861
+95
| +12% | +$45.5K | 0.03% | 165 |
|
|
2022
Q4 | $312K | Buy |
766
+211
| +38% | +$81.9K | 0.03% | 220 |
|
|
2022
Q3 | $181K | Sell |
555
-81
| -13% | -$29.8K | 0.02% | 290 |
|
|
2022
Q2 | $223K | Sell |
636
-27
| -4% | -$11K | 0.02% | 260 |
|
|
2022
Q1 | $363K | Buy |
663
+217
| +49% | +$114K | 0.03% | 193 |
|
|
2021
Q4 | $294K | Buy |
446
+241
| +118% | +$151K | 0.03% | 219 |
|
|
2021
Q3 | $127K | Buy |
205
+2
| +1% | +$1.34K | 0.01% | 353 |
|
|
2021
Q2 | $128K | Buy |
203
+5
| +3% | +$2.76K | 0.01% | 333 |
|
|
2021
Q1 | $97K | Sell |
198
-4
| -2% | -$2K | 0.01% | 344 |
|
|
2020
Q4 | $101K | Buy |
202
+73
| +57% | +$32.7K | 0.01% | 308 |
|
|
2020
Q3 | $51K | Buy |
129
+7
| +6% | +$2.59K | 0.01% | 368 |
|
|
2020
Q2 | $40K | Sell |
122
-120
| -50% | -$34.7K | 0.01% | 394 |
|
|
2020
Q1 | $59K | Buy |
242
+44
| +22% | +$11.5K | 0.02% | 205 |
|
|
2019
Q4 | $52K | Buy |
198
+193
| +3,860% | +$50.9K | 0.01% | 185 |
|
|
2019
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 401 |
|
|
2019
Q2 | $1K | Sell |
5
-5
| -50% | -$1.23K | ﹤0.01% | 367 |
|
|
2019
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 287 |
|
|
2018
Q4 | $2K | Buy |
+10
| New | +$2.05K | ﹤0.01% | 464 |
|
Other funds holding IDXX
Ellevest Inc's IDXX Position: Q2 2026 in Review
Ellevest Inc reduced its Idexx Laboratories (IDXX) stake by 3.8% in Q2 2026, selling an estimated $30.8K and leaving 1,405 shares worth $740K. The position accounts for 0.09% of the portfolio, ranked #168.
Ellevest Inc first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $901K in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Ellevest Inc held 1,405 shares of Idexx Laboratories worth $740K as of Q2 2026.
- Ellevest Inc sold 55 Idexx Laboratories shares in Q2 2026, an estimated $30.8K.
- Idexx Laboratories made up 0.09% of Ellevest Inc's portfolio in Q2 2026, its #168 holding.
- Ellevest Inc first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
- Ellevest Inc's Idexx Laboratories position peaked at $901K in Q3 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.